Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Atorvastatin Calcium Tablets

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Unknown2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06037707CompletedPrimary

Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit

NCT05534074Unknown

University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry

NCT05839236Phase 1Unknown

COVID-19 Vaccination Detoxification in LDL-C

Showing all 3 trials

Research Network

Common Treatments

  • Atorvastatin Calcium Tablets1

Active Sponsors

  • Ayse Zeynep Turan1
  • University Hospital, Ioannina1
  • Yang I. Pachankis1

Top Investigators

Related Conditions

  • Covid19 Respiratory Infection2
  • Covid 19 Associated Coagulopathy1
  • Covid19 Vaccine Adverse Reaction1
  • Covid19associated Pneumonia1
  • Covid19 Pandemic1

Activity Timeline